Growth hormone, insulin-like growth factors, and the skeleton

A Giustina, G Mazziotti, E Canalis - Endocrine reviews, 2008 - academic.oup.com
Abstract GH and IGF-I are important regulators of bone homeostasis and are central to the
achievement of normal longitudinal bone growth and bone mass. Although GH may act …

Mortality in patients with pituitary disease

M Sherlock, J Ayuk, JW Tomlinson… - Endocrine …, 2010 - academic.oup.com
Pituitary disease is associated with increased mortality predominantly due to vascular
disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor …

Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models

DE Berryman, JS Christiansen, G Johannsson… - Growth Hormone & IGF …, 2008 - Elsevier
Animal models are fundamentally important in our quest to understand the genetic,
epigenetic, and environmental factors that contribute to human aging. In comparison to …

Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH—an update

C Gazzaruso, M Gola, I Karamouzis… - The Journal of …, 2014 - academic.oup.com
Context: GH deficiency (GHD) of the adult is a clinical condition characterized by the
presence of several traditional and emerging cardiovascular risk factors that can significantly …

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults–a KIMS database analysis

R Abs, U Feldt-Rasmussen, AF Mattsson… - European Journal of …, 2006 - academic.oup.com
Objective The aim of the present study was to clarify the relationship between GH deficiency
(GHD) and some cardiovascular risk factors and to analyse the effect of GH replacement …

Fifteen years of GH replacement improves body composition and cardiovascular risk factors

M Elbornsson, G Götherström, I Bosæus… - European journal of …, 2013 - academic.oup.com
Objective Few studies have determined the effects of more than 5–10 years of GH
replacement in adults on body composition and cardiovascular risk factors. Design/patients …

[PDF][PDF] Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis

M Barake, A Klibanski, NA Tritos - J Clin Endocrinol Metab, 2014 - researchgate.net
Objective: GH deficiency is associated with decreased bone mineral density (BMD) and
increased fracture risk. Because the effects of recombinant human GH (rhGH) therapy on …

Blunted diurnal cortisol pattern is associated with frailty: a cross-sectional study of 745 participants aged 65 to 90 years

H Johar, RT Emeny, M Bidlingmaier… - The Journal of …, 2014 - academic.oup.com
Objective: GH deficiency is associated with decreased bone mineral density (BMD) and
increased fracture risk. Because the effects of recombinant human GH (rhGH) therapy on …

Age-related changes in body composition of bovine growth hormone transgenic mice

AJ Palmer, MY Chung, EO List, J Walker… - …, 2009 - academic.oup.com
GH has a significant impact on body composition due to distinct anabolic and catabolic
effects on lean and fat mass, respectively. Several studies have assessed body composition …

Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk

L Giovannini, G Tirabassi, G Muscogiuri… - Endocrine …, 2015 - jstage.jst.go.jp
Adult growth hormone deficiency (GHD) is a well defined clinical condition, which is
characterized by abnormal body composition, impaired physical activity and decreased …